Ahead of World Obesity Day, colleagues from the World Obesity Federation, International Diabetes Federation, World Heart Federation and the Medicines Patent Pool have published a new open‑access Comment in The Lancet Global Health on: “Therapies based on GLP‑1 receptor agonists: significance, challenges, and opportunities.” The paper reflects a turning point in global obesity care. Following landmark […]
08 March 2026
Keyword